| Literature DB >> 26692551 |
Fanrong Ai1,2, Carolina A Ferreira3, Feng Chen2, Weibo Cai2,3,4,5.
Abstract
Over the last decade, radiolabeled iron oxide nanoparticles have been developed as promising contrast agents for dual-modality positron emission tomography/magnetic resonance imaging (PET/MRI) or single-photon emission computed tomography/magnetic resonance imaging (SPECT/MRI). The combination of PET (or SPECT) with MRI can offer synergistic advantages for noninvasive, sensitive, high-resolution, and quantitative imaging, which is suitable for early detection of various diseases such as cancer. Here, we summarize the recent advances on radiolabeled iron oxide nanoparticles for dual-modality imaging, through the use of a variety of PET (and SPECT) isotopes by using both chelator-based and chelator-free radiolabeling techniques. WIREs Nanomed Nanobiotechnol 2016, 8:619-630. doi: 10.1002/wnan.1386.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26692551 PMCID: PMC4911308 DOI: 10.1002/wnan.1386
Source DB: PubMed Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol ISSN: 1939-0041